Advertisement PerkinElmer signs contract with ID Biological Systems - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PerkinElmer signs contract with ID Biological Systems

PerkinElmer, a provider of technology, services and solutions, has entered into a contract with ID Biological Systems of Greenville, South Carolina, US, to become its exclusive, worldwide distributor for specimen collection cards used by newborn screening programs worldwide.

Hospitals and physicians use these dried blood spot cards to collect and transport blood specimens, which are later analyzed by public health laboratories. The agreement is intended to deliver a consistent, high-quality supply of sample collection cards designed to customer specifications in laboratories worldwide.

ID Biological Systems will produce the cards using Ahlstrom grade 226 filter paper which is manufactured to the CLSI standard for blood collection on filter paper for newborn screening programs. The paper has been successfully tested to this standard by the Centers for Disease Control and Prevention’s newborn screening quality program and other third party testing facilities.

Ann-Christine Sundell, president of genetic screening at PerkinElmer, said: “To secure the supply and delivery of FDA-approved high-quality specimen cards is a priority for PerkinElmer and our newborn screening customers. This agreement expands our offering with a high-quality product, and provides IDB systems with a strong and proven distribution channel for its product.”